141 related articles for article (PubMed ID: 25941619)
1. Vitamin B6 improves the immunogenicity of cisplatin-induced cell death.
Aranda F; Bloy N; Galluzzi L; Kroemer G; Senovilla L
Oncoimmunology; 2014 Oct; 3(9):e955685. PubMed ID: 25941619
[TBL] [Abstract][Full Text] [Related]
2. Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer.
Aranda F; Bloy N; Pesquet J; Petit B; Chaba K; Sauvat A; Kepp O; Khadra N; Enot D; Pfirschke C; Pittet M; Zitvogel L; Kroemer G; Senovilla L
Oncogene; 2015 Jun; 34(23):3053-62. PubMed ID: 25065595
[TBL] [Abstract][Full Text] [Related]
3. Vitamin B6 metabolism influences the intracellular accumulation of cisplatin.
Galluzzi L; Marsili S; Vitale I; Senovilla L; Michels J; Garcia P; Vacchelli E; Chatelut E; Castedo M; Kroemer G
Cell Cycle; 2013 Feb; 12(3):417-21. PubMed ID: 23287530
[TBL] [Abstract][Full Text] [Related]
4. Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses.
Galluzzi L; Vacchelli E; Michels J; Garcia P; Kepp O; Senovilla L; Vitale I; Kroemer G
Oncogene; 2013 Oct; 32(42):4995-5004. PubMed ID: 23334322
[TBL] [Abstract][Full Text] [Related]
5. Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress.
Martins I; Kepp O; Schlemmer F; Adjemian S; Tailler M; Shen S; Michaud M; Menger L; Gdoura A; Tajeddine N; Tesniere A; Zitvogel L; Kroemer G
Oncogene; 2011 Mar; 30(10):1147-58. PubMed ID: 21151176
[TBL] [Abstract][Full Text] [Related]
6. Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines.
Bando T; Fujimura M; Kasahara K; Matsuda T
Anticancer Res; 1998; 18(2A):1085-9. PubMed ID: 9615770
[TBL] [Abstract][Full Text] [Related]
7. Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer.
Yang Y; Zhang P; Zhao Y; Yang J; Jiang G; Fan J
Cancer Biol Ther; 2016 May; 17(5):515-25. PubMed ID: 26492332
[TBL] [Abstract][Full Text] [Related]
8. Role of thromboxane receptor on the intracellular accumulation of cis-diamminedichloroplatinum(II) in non-small-cell but not in small-cell lung cancer cell lines.
Bando T; Fujimura M; Kasahara K; Matsuda T
Anticancer Res; 1998; 18(2A):1079-84. PubMed ID: 9615769
[TBL] [Abstract][Full Text] [Related]
9. Vitamin B-6-Induced Neuropathy: Exploring the Mechanisms of Pyridoxine Toxicity.
Hadtstein F; Vrolijk M
Adv Nutr; 2021 Oct; 12(5):1911-1929. PubMed ID: 33912895
[TBL] [Abstract][Full Text] [Related]
10. Elevated pressure, a novel cancer therapeutic tool for sensitizing cisplatin-mediated apoptosis in A549.
Oh S; Kim Y; Kim J; Kwon D; Lee E
Biochem Biophys Res Commun; 2010 Aug; 399(1):91-7. PubMed ID: 20643104
[TBL] [Abstract][Full Text] [Related]
11. ER stress and autophagy are involved in the apoptosis induced by cisplatin in human lung cancer cells.
Shi S; Tan P; Yan B; Gao R; Zhao J; Wang J; Guo J; Li N; Ma Z
Oncol Rep; 2016 May; 35(5):2606-14. PubMed ID: 26985651
[TBL] [Abstract][Full Text] [Related]
12. Identification of the pdxK gene that encodes pyridoxine (vitamin B6) kinase in Escherichia coli K-12.
Yang Y; Zhao G; Winkler ME
FEMS Microbiol Lett; 1996 Jul; 141(1):89-95. PubMed ID: 8764513
[TBL] [Abstract][Full Text] [Related]
13. Alleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damage.
Wu Y; Ma C; Zhao H; Zhou Y; Chen Z; Wang L
Reprod Biol Endocrinol; 2018 Sep; 16(1):85. PubMed ID: 30176887
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
15. Effect of proton pump inhibitor on cell growth and sensitivity to cis-diamminedichloroplatinum(II) in non-small cell lung cancer cell lines.
Bando T; Kasahara K; Shibata K; Nakatsumi Y; Fujimura M; Matsuda T
Anticancer Res; 1994; 14(6B):2727-30. PubMed ID: 7872708
[TBL] [Abstract][Full Text] [Related]
16. Autophagy inhibition of cancer stem cells promotes the efficacy of cisplatin against non-small cell lung carcinoma.
Hao C; Liu G; Tian G
Ther Adv Respir Dis; 2019; 13():1753466619866097. PubMed ID: 31368411
[TBL] [Abstract][Full Text] [Related]
17. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
Gao J; Meng Q; Zhao Y; Chen X; Cai L
BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
[TBL] [Abstract][Full Text] [Related]
18. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer.
Jiao P; Hou J; Yao M; Wu J; Ren G
Biomed Pharmacother; 2019 Sep; 117():109164. PubMed ID: 31252267
[TBL] [Abstract][Full Text] [Related]
19. Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor-alpha.
Mizutani Y; Bonavida B
Cancer; 1993 Aug; 72(3):809-18. PubMed ID: 8334635
[TBL] [Abstract][Full Text] [Related]
20. Drug-pyridoxal phosphate interactions.
Ebadi M; Gessert CF; Al-Sayegh A
Q Rev Drug Metab Drug Interact; 1982; 4(4):289-331. PubMed ID: 6087425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
